These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19616706)

  • 1. Antiretroviral roll-out: the problem of second-line therapy.
    Boyd M; Emery S; Cooper DA
    Lancet; 2009 Jul; 374(9685):185-6. PubMed ID: 19616706
    [No Abstract]   [Full Text] [Related]  

  • 2. National adult antiretroviral therapy guidelines in resource-limited countries: concordance with 2003 WHO guidelines?
    Beck EJ; Vitoria M; Mandalia S; Crowley S; Gilks CF; Souteyrand Y
    AIDS; 2006 Jul; 20(11):1497-502. PubMed ID: 16847404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV prevention and treatment in Africa.
    Laurence J
    AIDS Patient Care STDS; 2000 Aug; 14(8):399-400. PubMed ID: 10977967
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of antiretroviral therapy in resource-limited countries in 2006: distribution and uptake of first- and second-line regimens.
    Renaud-Théry F; Nguimfack BD; Vitoria M; Lee E; Graaff P; Samb B; Perriëns J
    AIDS; 2007 Jul; 21 Suppl 4():S89-95. PubMed ID: 17620758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2005).
    Gazzard B;
    HIV Med; 2005 Jul; 6 Suppl 2():1-61. PubMed ID: 16011536
    [No Abstract]   [Full Text] [Related]  

  • 6. Beyond first-line HIV treatment regimens: the current state of antiretroviral regimens, viral load monitoring, and resistance testing in resource-limited settings.
    Kumarasamy N; Krishnan S
    Curr Opin HIV AIDS; 2013 Nov; 8(6):586-90. PubMed ID: 24100872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa.
    Schuelter-Trevisol F; Trevisol DJ; Fuchs SC
    AIDS; 2009 Apr; 23(7):871-2; author reply 872-3. PubMed ID: 19363333
    [No Abstract]   [Full Text] [Related]  

  • 8. HIV treatment guidelines.
    Birth; 2013 Sep; 40(3):210. PubMed ID: 24772491
    [No Abstract]   [Full Text] [Related]  

  • 9. Inequalities in health: access to treatment for HIV/AIDS.
    Giuliano M; Vella S
    Ann Ist Super Sanita; 2007; 43(4):313-6. PubMed ID: 18209264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [5th French-speaking conference on HIV/AIDS (Casablanca, 28-31 March 2010)].
    Milleliri JM; Goudjo A
    Med Trop (Mars); 2010 Jun; 70(3):226-8. PubMed ID: 20734588
    [No Abstract]   [Full Text] [Related]  

  • 11. Are the best antiretrovirals being used in Africa?
    John L; Kambugu A; Songa PM; Castelnuovo B; Colebunders R; Kamya M
    J HIV Ther; 2006 Mar; 11(1):11-5. PubMed ID: 16706250
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiretroviral therapy where resources are limited.
    Reynolds SJ; Bartlett JG; Quinn TC; Beyrer C; Bollinger RC
    N Engl J Med; 2003 May; 348(18):1806-9. PubMed ID: 12724489
    [No Abstract]   [Full Text] [Related]  

  • 13. HIV therapeutics: points from the recent literature.
    Laurence J
    AIDS Read; 2003 Jul; 13(7):305, 307. PubMed ID: 12889448
    [No Abstract]   [Full Text] [Related]  

  • 14. Monitoring HIV antiretroviral therapy in resource-limited settings: time to avoid costly outcomes.
    Sawe FK; McIntyre JA
    Clin Infect Dis; 2009 Aug; 49(3):463-5. PubMed ID: 19569971
    [No Abstract]   [Full Text] [Related]  

  • 15. WHO's new HIV guidelines: opportunities and challenges.
    Mayer K; Beyrer C
    Lancet; 2013 Jul; 382(9889):287-8. PubMed ID: 23890033
    [No Abstract]   [Full Text] [Related]  

  • 16. Avoid a different standard of care when applying results of Development of Antiretroviral Therapy in Africa (DART) study.
    Sayana S; Manchanda R; Khanlou H; Saavedra J; Reis P; Weinstein M
    J Acquir Immune Defic Syndr; 2010 Jan; 53(1):153-4. PubMed ID: 20035167
    [No Abstract]   [Full Text] [Related]  

  • 17. Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching.
    Elliott JH; Lynen L; Calmy A; De Luca A; Shafer RW; Zolfo M; Clotet B; Huffam S; Boucher CA; Cooper DA; Schapiro JM
    AIDS; 2008 Oct; 22(16):2053-67. PubMed ID: 18753937
    [No Abstract]   [Full Text] [Related]  

  • 18. Towards national and global measurement of antiretroviral therapy effectiveness.
    Suthar AB; Calleja JMG; Weiler GA
    Lancet Infect Dis; 2014 Jan; 14(1):14-15. PubMed ID: 24355032
    [No Abstract]   [Full Text] [Related]  

  • 19. Evolution of HIV treatment guidelines in high- and low-income countries: converging recommendations.
    Richardson ET; Grant PM; Zolopa AR
    Antiviral Res; 2014 Mar; 103():88-93. PubMed ID: 24374148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Brazilian experiment: HIV drugs for all.
    Flaer PJ; Younis MZ
    J Health Care Finance; 2009; 36(2):90-6. PubMed ID: 20499725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.